Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia

NCT00824265

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations
  • Novartis Investigative Site Boca Raton, Florida, United States
  • Novartis Investigative Site Chicago, Illinois, United States
  • Novartis Investigative Site Clinton, Maryland, United States
  • Novartis Investigative Site Kansas City, Missouri, United States
View all 135 locations
View Trial Details
Completed

Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma

NCT00903968

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Cape Cod Hospital Hyannis, Massachusetts, United States
  • Milford Hospital Milford, Massachusetts, United States
  • Newton-Wellesley Hospital Newton, Massachusetts, United States
View Trial Details
Completed

A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status

NCT00462761

Conditions
AML, Acute Myeloid Leukemia, Aortic aneurysm, familial thoracic 4, +18 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Chemotherapy and Immunotherapy Clinic Tbilisi, Georgia
View Trial Details

Related conditions